PRRT2 and neoplasm: Contrary to the classic anti-tumor effect of PKC activators, in the present research, we found that compound A promoted the apoptosis of HepG2 cells, conversely regulating PKC δ-ERK and STAT signaling pathways to inhibit M1 and M2 macrophage polarization.